Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Journals Home

SIGN IN

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Narrow View

NARROW

Content Type

Meeting Abstract (47)
Journal Articles (3)

Journal

Investigative Ophthalmology & Visual Science (50)

Article Type

ARVO Annual Meeting Abstract (47)
Retina (2)
Cornea (1)

Topics

Eye Anatomy and Disorders (3)
Pharmacology (3)
Immunology and Microbiology (2)
Retina (2)
Vitreous Disorders (2)
Cornea (1)
Surgery (1)

Tags

alteplase (1)
biocompatibility (1)
biopolymers (1)
burkina faso (1)
cornea (1)
crystal structure (1)
endothelial cells (1)
hyaluronic acid (1)
hydrogel (1)
hydrogels (1)

Specify Date Range

From: To: Apply

Showing 1 – 20 of 50

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

A clinical grading scale to assess ocular involvement in juvenile CLN3 disease

Simon Dulz; Jan Wildner; Christoph Schwering; Miriam Nickel; Eva Wibbeler; Martin S Spitzer; Angela schulz; Yevgeniya Atiskova

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1054. doi:

ARVO Annual Meeting Abstract July 2019

Retinal degeneration in patients with CLN2 disease

Simon Dulz; Christoph Schwering; Eva Wibbeler; Miriam Nickel; Martin Spitzer; Angela Schulz; Yevgeniya Atiskova

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3618. doi:

ARVO Annual Meeting Abstract July 2019

Effect of the Hydrus microstent with combined phacoemulsification on intraocular pressure

Maria Katharina Casagrande; Leonie Meier; Sanaz Farrokhi; Martin Spitzer; Maren Klemm

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3740. doi:

ARVO Annual Meeting Abstract July 2019

Thiolated cross-linked hydrogel as a vitreous substitute – a 6-month follow-up study

Lisa Pohl; Nele Heider; Jose Hurst; Martin Prinz; Christine Hohenadl; Charlotte Reither; Kai Januschowski; Sven Schnichels; Martin Spitzer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6608. doi:

ARVO Annual Meeting Abstract July 2019

Ahmed valve implantation for secondary glaucoma in elderly uveitis patients

Nils Steinhorst Steinhorst; Maria Katharina Casagrande; Martin Spitzer; Nicole Stuebiger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6642. doi:

ARVO Annual Meeting Abstract July 2019

Brimonidine loaded lipid DNA-nanoparticles as an improved and novel treatment option for glaucoma

Sven Schnichels; Katharina Frößl; Jan Willem de Vries; Marina Löscher; Karl Bartz-Schmidt; Andreas Herrmann; Martin S Spitzer; José Hurst

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1703. doi:

ARVO Annual Meeting Abstract July 2018

DNA Nanoparticles for the Treatment of Retinal Diseases: in-vivo results

Sven Schnichels; David Simmang; Lisa Strudel; Jose Hurst; Jan Willem de Vries; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5683. doi:

ARVO Annual Meeting Abstract July 2018

Lipid DNA Nanoparticles – a versatile vehicle for anterior segment drug delivery

Lisa Strudel; Jose Hurst; Jan Willem de Vries; Agnieszka Gruszka; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5684. doi:

ARVO Annual Meeting Abstract July 2018

Hyaluronic acid based cross-linked hydrogels – a biosafe, sufficient tamponade of the vitreous body

Lisa Katharina Pohl; Kai Januschowski; Sven Schnichels; Jose Hurst; Christine Hohenadl; Charlotte Reither; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5931. doi:

ARVO Annual Meeting Abstract June 2017

Travoprost loaded lipid DNA-nanoparticles as a new and improved treatment for glaucoma

Sven Schnichels; Jan Willem de Vries; Agnieszka Gruszka; Karl Ulrich Bartz-Schmidt; Sascha Dammeier; Andreas Herrmann; Martin Stephan Spitzer; Jose Hurst

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4105. doi:

ARVO Annual Meeting Abstract June 2017

Lipid modified aptamers as vehicles for ophthalmic drug delivery

Lisa Strudel; Jose Hurst; Agnieszka Gruszka; Ullrich Hagel; Jan Willem de Vries; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4107. doi:

ARVO Annual Meeting Abstract June 2017

Efficacy of two different thiol-modified crosslinked hyaluronate formulations compared to silicone oil in a model of retinal detachment

Martin Stephan Spitzer; Nele Schneider; Jose Hurst; Christine Hohenadl; Kai Januschowski; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4174. doi:

ARVO Annual Meeting Abstract June 2017

Picosecond infrared laser - fibre-assisted-sclerostomy (PIRL-FAST): A first proof of principle analysis

Juliane Mehlan; Stephanie Uschold; Nils- Owe Hansen; Tobias Gosau; Dennis Eggert; Martin Stephan Spitzer; Hannes Petersen; Udo Schumacher; Stephan Johannes Linke; Dwayne Miller

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4990. doi:

ARVO Annual Meeting Abstract June 2017

Measurement of SD-OCT Bruch’s Membrane Opening Minimum Rim Width: Method to correct for Optic Nerve Circumference

Robert Kromer; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1310. doi:

ARVO Annual Meeting Abstract June 2017

SD-OCT imaging of retinal degeneration in juvenile CLN3 disease - a potential adjunctive tool for global neurodegenerative assessment

Simon Dulz; Yevgenija Atiskova; Jan-Niklas Hochstein; Lars Wagenfeld; Miriam Nickel; Jan Sedlacik; Christoph Schwering; Martin Stephan Spitzer; Alfried Kohlschütter; Angela Schulz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1316. doi:

ARVO Annual Meeting Abstract June 2017

Establishment Of A Porcine Corneal Endothelial Organ Culture Model

Maximilian Schultheiss; Berenike Kunzmann; Christian Klameth; Karl-Ulrich Bartz-Schmidt; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1464. doi:

ARVO Annual Meeting Abstract September 2016

Hypothermia protects retinal ganglion cells from cell death in an organotypic ischemia model

Jose Hurst; Patricia Klemm; Matthias Blak; Thoralf Herrmann; Max Schultheiss; Karl-Ulrich Bartz-Schmidt; Guenther Zeck; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4414. doi:

ARVO Annual Meeting Abstract September 2016

Novel thixotropic silicone oils – the ketchup bottle approach for trocar-guided vitrectomy

Christian Klameth; Christian Lingenfelder; Christoph Lindner; Berenike Kunzmann; Kai Januschowski; Karl-Ulrich Bartz-Schmidt; Max Schultheiss; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4477. doi:

ARVO Annual Meeting Abstract September 2016

In-vitro and in-vivo toxicological evaluation of alkyl-modified DNA nanoparticles

Katharina Froessl; Jan Willem De Vries; Johanna Wude; Jose Hurst; Agnieszka Gruszka; Karl-Ulrich Bartz-Schmidt; Andreas Hermann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5054. doi:

ARVO Annual Meeting Abstract September 2016

Kanamycin loaded lipid modified DNA-Nanoparticles with superior bacterial growth inhibition

Lisa Strudel; Jose Hurst; Jan Willem De Vries; Agnieszka Gruszka; Karl-Ulrich Bartz-Schmidt; Andreas Hermann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5055. doi:

« Previous

1 2 3

Next 20 Results »

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept